Memphasys secures UK market entry, accelerating commercial rollout
Memphasys has entered the U.K. fertility market with four IVF groups putting in commercial orders to trial its Felix system.
Market Cap $702.4M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
ASX News